Modern, intuitive, and reliable thermal cyclers excel at optimizing sequencing, cloning, and genotyping throughput. Choosing the right thermal cycler can be a daunting task. Among the considerations ...
Co-Diagnostics Inc. CODX on Wednesday said CoSara Diagnostics Pvt. Ltd, its joint venture in India, is initiating clinical ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Featuring a simple workflow with minimal hands-on time, the benchtop platform is disruptively priced at $30,000 -- enabling access to a broader community. The system is currently with early access ...
Life Technologies Corporation has announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical ...
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of ...
The Pharos V8 is based on the company’s patented Pulse Controlled Amplification (PCA) technology. Conventional PCR platforms rely on thermocyclers that the firm said can limit reaction speed. PCA uses ...
A joint team from China recently provided a sensitive, multiplexing, quantitative detection method for the early diagnosis and targeted therapy of myeloproliferative neoplasms, a type of chronic ...
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution Mohal Sarabhai, CEO of CoSara, remarked, "We believe this landmark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results